International Journal of CAR T-Cell Therapy
Reaches 1 People per Month
The International Journal of CAR T-Cell Therapy, a peer-reviewed, open-access journal, will be published by Sunvalley Communication, the publisher of ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine is set to premiere in the Summer of 2021.The International Journal of CAR T-Cell Therapy is part of the Physician’s Weekly Oncology Network, an oncology focused online publication, digital audio (broadcast and podcast) and education platform.The Physician’s Weekly Oncology Network offers news, opinion, conference coverage and in-depth interviews with the most highly respected and internationally recognized oncology and hematology experts and Key Opinion Leaders who weigh in on landmark and practice changing research and trending topics affecting the oncology community.
The Physician’s Weekly Oncology Network also offers physicians and other healthcare professionals accredited Continuing Medical Education (CME) activities.
Bionic ID: 540375
Advertising Options
Below are International Journal of CAR T-Cell Therapy advertising placement options to consider in your media planning and media buying.
-
Magazine Advertising
- 1/2 Page - 1/2 Page
- 1/3 Page - 1/3 Page
- 1/4 Page - 1/4 Page
- 1/6 Page - 1/6 Page
- Full Page - Full Page
- Half Page - Half Page
-
Social Advertising
- Facebook Post
- LinkedIn Post
- Twitter Post
-
Video Advertising
- YouTube Post
-
Online Display Advertising
- Banner 728 x 90 - 728x90 - 1 Reach - $ 1,850.00 CPM
- Large Leaderboard (970 x 250) - 970 x 250 - 1 Reach - $ 1,850.00 CPM
Learn More
To learn more about the International Journal of CAR T-Cell Therapy program, submit a request for information. Your request will be sent immediately to the Sunvalley Communication ad sales team.
Place an Order
To place an order, contact International Journal of CAR T-Cell Therapy or order electronically through Bionic Media Buying Software using ID 540375.